Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2.
Journal Information
Full Title: Clin Rev Allergy Immunol
Abbreviation: Clin Rev Allergy Immunol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Allergy and Immunology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interest K.B. has received grant research support and/or speaker fees from CSL Behring and Shire (a Takeda company), outside the submitted work. D.C. reports consultancy fees from BioCryst, CSL Behring, Pharming, Pharvaris and Shire (a Takeda company), outside the submitted work. L.F. declares no conflict of interest."
"Compliance with Ethical Standards: Conflicts of InterestK.B. has received grant research support and/or speaker fees from CSL Behring and Shire (a Takeda company), outside the submitted work.D.C. reports consultancy fees from BioCryst, CSL Behring, Pharming, Pharvaris and Shire (a Takeda company), outside the submitted work.L.F. declares no conflict of interest. Conflicts of Interest: K.B. has received grant research support and/or speaker fees from CSL Behring and Shire (a Takeda company), outside the submitted work.: D.C. reports consultancy fees from BioCryst, CSL Behring, Pharming, Pharvaris and Shire (a Takeda company), outside the submitted work.: L.F. declares no conflict of interest."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025